ClinicalTrials.gg
Not yet recruitingNCT07231198micropl_perioUpdated Nov 19, 2026

Detection of Microplastics in Patients With Periodontitis

An observational study in Periodontal Diseases and Periodontitis, sponsored by Sigmund Freud PrivatUniversitat. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Primary conditionPeriodontitisRegistry: Periodontal DiseasesReclassifiedWhy we changed it
Registry
Periodontal Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Periodontitis
Why
  1. The study's listed conditions name Periodontitis, a narrower term within Periodontal Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Sigmund Freud PrivatUniversitat · Observational

How we know

Updated Nov 19, 2026Start date movedPrimary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
25
Ages
18 Years and older
Sex
All
01

Study summary

Plastic particles known as microplastics are now a ubiquitous part of the environment. Human exposure to microplastics occurs through the consumption of contaminated food and polluted air, which affect the intestinal system. Several studies have detected the presence of microplastics in various parts of the human digestive system, e.g., in feces. Unfortunately, little is known about the presence of microplastics in the mouth as the primary part of the digestive system. Periodontal pockets can be considered an ideal deposition site for microplastics. Since microplastics are suspected of being an immunomodulatory factor, there is great interest in their presence in subgingival plaque and their possible exacerbation of chronic inflammatory diseases such as periodontitis. The following study aims to clarify the presence, classification, and concentration of microplastics in subgingival plaque. No comparable study has been identified to date.

02

Conditions studied

  • Periodontal Diseases
  • Periodontitis

Browse trials for

Keywords

  • periodontitis
  • microplastics
03

In context

Periodontitis Reclassified

1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.

This study's planned enrollment of 25 is below the median of 90 across 379 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Sigmund Freud PrivatUniversitat is the lead sponsor of 12 studies on the registry; 10 are open to participants now.

Compared within Periodontitis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontal Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with periodontitis, stage 3 or 4, with a full mouth probing score at the Department of Periodontology, Dental Clinics, Sigmund Freud University, Vienna, Austria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 and over
  • Gender: Female / male / diverse
  • Patients

    • who have been diagnosed with stage III and IV periodontitis.
    • who have not yet started periodontal treatment.
    • who still have at least 20 teeth. Providing written consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients

    • who have already been treated for periodontitis
    • who have already undergone/begun periodontitis treatment
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
25 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • patients with periodontitis, stage 3 or 4

    Status assessment with supragingival cleaning Sample collection with sterile universal curette (steel) from the bottom of the pockets of the 4 deepest gum pockets (ST \>= 5mm) pooled in ultrapure water

06

What researchers measure

Primary outcomes

  1. Microplastics

    number of patients with periodontitis with microplastics in periodontal pockets, quantification of microplastic particles in periodontal pockets, qualitative analysis of microplastic

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Francis DL, Pape Reddy SS. Microplastics in the Pathogenesis of Periodontal Diseases: A Narrative Review. Ann Glob Health. 2025 Oct 3;91(1):69. doi: 10.5334/aogh.4861. eCollection 2025. PubMed 41079032 ↗

Individual participant data

Plan to share: Yes — microplastic findings

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Jan 2027; primary completion for Jul 2027, 6 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: start Feb 2026 → Jan 2027 and primary completion Feb 2027 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2025
First posted
Nov 17, 2025
StartEst.
Jan 1, 2027was Feb 2026
Primary completionEst.
Jul 1, 2027was Feb 2027
CompletionEst.
Feb 1, 2028
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Feb 1, 2026→Jan 1, 2027
Nov 19, 2026
Primary completion
Feb 1, 2027→Jul 1, 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Start date Feb 1, 2026→Jan 1, 2027
    Primary completion Feb 1, 2027→Jul 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07231198
Lead sponsor
Sigmund Freud PrivatUniversitat
Responsible party
Hady Haririan (Prof., Sigmund Freud PrivatUniversitat) — Principal investigator
First posted
Nov 17, 2025
Start date
Jan 1, 2027 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Feb 1, 2028 (estimated)
Last update
Nov 19, 2026

Study contacts

Hady Haririan, Univ.-Prof., Dr., PhD, MSc
Contact
hady.haririan@med.sfu.ac.at
+4317201966

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion